| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.0058 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |